Thus, application of RNAi-based therapeutics for the knockdown of S100A4 expression in tumor cells might be a practical approach to effectively and efficiently suppress cancer metastasis and prolong the disease-free survival of cancer patients. The gene discussed is S100A4; the disease is cancer.